Earnings History Data for Histogen Inc. (HSTO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Histogen Inc.

Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products. Histogen Inc., formerly known as Conatus Pharmaceuticals Inc., is based in San Diego, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-08-2022	AH	4:05 PM ET (Aug 11)	HSTO	Histogen Inc.	8.42	-1.55	-1.40	2.00	Histogen GAAP EPS of -$1.55 [8/11/2022 4:35 PM]	2.00	-0.12 (-5.66%)	1.97	-0.15 (-7.08%)	1.88 - 18.40	508,377	1,180,000	30,840
Histogen GAAP EPS of -$1.55 [8/11/2022 4:35 PM] Histogen stock down 8% after Q2 loss, on track for six-day losing streak [8/12/2022 2:49 PM] Histogen Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-11-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	HSTO	Histogen Inc.	8.49	-0.01	-0.07	-0.14	Histogen GAAP EPS of -$0.01, revenue of $3.7M [5/12/2022 4:26 PM]	0.1663	0.0 (0.12%)	0.18	0.02 (10.96%)	0.15 - 1.23	1,529,060	1,040,000	10,396
Histogen GAAP EPS of -$0.01, revenue of $3.7M [5/12/2022 4:26 PM] Histogen Reports First Quarter 2022 Financial Results and Provides Business Update [May-12-22 04:05PM]
10-03-2022	AH	4:05 PM ET (Mar 10)	HSTO	Histogen Inc.	10.74	-0.07	-0.11	-0.26	Histogen GAAP EPS of -$0.07, revenue of $0.5M [3/10/2022 5:42 PM]	0.2190	-0.02 (-8.10%)	0.24	0.0 (0.00%)	0.20 - 1.55	268,165	1,040,000	11,884
Histogen GAAP EPS of -$0.07, revenue of $0.5M [3/10/2022 5:42 PM] Histogen Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update [Mar-10-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	HSTO	Histogen Inc.	30.10	-0.09	-0.11	-0.27		0.6197	-0.02 (-3.13%)	0.66	0.03 (3.94%)	0.61 - 1.98	1,124,640	670,000	1,289
Histogen Reports Third Quarter 2021 Earnings and Provides Business Update [Nov-10-21 04:05PM]
11-08-2021	AH		HSTO	Histogen Inc.	35.86	-0.10	0.00	-0.46	Histogen reports Q2 results [8/11/2021 4:42 PM]	0.8551	-0.06 (-7.05%)	0.88	-0.04 (-4.35%)	0.75 - 2.85	822,040	2,120,000	4,645
Histogen reports Q2 results [8/11/2021 4:42 PM] Histogen Reports Second Quarter 2021 Earnings and Provides Business Update [Aug-11-21 04:05PM]
13-05-2021	AH		HSTO	Histogen Inc.	33.96	-0.14	0.00	1.00	Histogen reports Q1 results [5/13/2021 5:04 PM]	0.9356	0.04 (3.91%)	0.91	0.01 (1.07%)	0.75 - 7.50	171,310	440,000	5,425
Histogen reports Q1 results [5/13/2021 5:04 PM] Histogen Reports First Quarter 2021 Earnings and Provides Business Update [May-13-21 04:01PM]
11-03-2021	AH		HSTO	Histogen Inc.	30.63	-0.26	0.00	-0.80	Histogen misses on revenue [3/11/2021 5:44 PM]	1.34	-0.08 (-5.63%)	1.27	-0.15 (-10.56%)	0.75 - 7.50	2,429,894	3,958,873	196,067
Histogen misses on revenue [3/11/2021 5:44 PM] Histogen Strengthens Board of Directors with Appointment of Industry Leader Susan Windham-Bannister, Ph.D. [Mar-10-21 04:05PM] Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update [Mar-11-21 04:01PM]